DCGO:NASDAQDocGo Inc. Analysis

DocGo Inc. (DCGO) is trading at a deep discount of $0.575, barely above its calculated support of $0.56 and well below the 20‑day SMA of $0.665, the 50‑day SMA of $0.732, and the 200‑day SMA of $1.15, underscoring a pronounced bearish trend. Technical momentum is weak, with a RSI of 35.7 indicating oversold conditions, a bearish MACD (line below signal) and a negative histogram, while the volume trend is increasing and volatility is extreme at 85.7% over 30 days. Fundamental metrics are equally troubling: revenue fell 38% year‑over‑year, gross margin sits at just 30.7%, operating margin is –43.3%, and the company posted a net loss with a trailing EPS of –1.84, though forward EPS is projected positive at 0.175. The balance sheet shows modest cash of $51M against $29M debt, yielding a high debt‑to‑equity ratio of 23, and return metrics (ROE –89%) are negative. Despite these challenges, the DCF model values the stock at $7.84, implying a staggering 265% upside, and management has guided 2026 revenue of $280‑$300M, suggesting potential upside if the turnaround succeeds. The market sentiment is currently in a “Greed” phase (Fear & Greed Index 65.98), but the combination of high beta (1.19), massive historical drawdown (‑78.6%), and sector‑specific regulatory exposure keeps risk elevated.